Toxicity of antiretroviral therapy and implications for drug development.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 624, doi. 10.1038/nrd1151
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2003 AND VI 2 AND IP 8
Results: 22
1
2
Pharmacophylogenomics: genes, evolution and drug targets.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 613, doi. 10.1038/nrd1152
- By:
- Publication type:
- Article
3
Therapeutic approaches to innate immunity: severe sepsis and septic shock.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 635, doi. 10.1038/nrd1153
- By:
- Publication type:
- Article
4
A guide to drug discovery: Logistics of process R&D: transforming laboratory methods to manufacturing scale.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 654, doi. 10.1038/nrd1154
- By:
- Publication type:
- Article
5
Reviews and comment from the nature publishing group.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 667, doi. 10.1038/nrd1160
- Publication type:
- Article
6
Opinion: Drug research: myths, hype and reality.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 665, doi. 10.1038/nrd1156
- By:
- Publication type:
- Article
7
Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism.
- Published in:
- 2003
- By:
- Publication type:
- research
8
From the analyst's couch: Oncology's trials.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 609, doi. 10.1038/nrd1158
- By:
- Publication type:
- Article
9
Fresh from the pipeline: Bortezomib.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 611, doi. 10.1038/nrd1159
- By:
- Publication type:
- Article
10
Mild cognitive impairment clinical trials.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 646, doi. 10.1038/nrd1155
- By:
- Publication type:
- Article
11
Rational drug design: We're prodrug!
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 603, doi. 10.1038/nrd1161
- By:
- Publication type:
- Article
12
Neurodegenerative diseases: As one door closes, another opens.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 604, doi. 10.1038/nrd1162
- By:
- Publication type:
- Article
13
Lead discovery: Guided by nature.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 607, doi. 10.1038/nrd1163
- By:
- Publication type:
- Article
14
Neurodegenerative diseases: Spot the difference.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 608, doi. 10.1038/nrd1164
- By:
- Publication type:
- Article
15
High-throughput screening: Combine and conquer.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 606, doi. 10.1038/nrd1165
- By:
- Publication type:
- Article
16
Diabetes: Connectin' through adiponectin.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 606, doi. 10.1038/nrd1166
- By:
- Publication type:
- Article
17
Antifungals: Doing the two step.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 605, doi. 10.1038/nrd1167
- By:
- Publication type:
- Article
18
Virtual screening: Artificial intelligence.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 604, doi. 10.1038/nrd1168
- By:
- Publication type:
- Article
19
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 608, doi. 10.1038/nrd1169
- Publication type:
- Article
20
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 607, doi. 10.1038/nrd1170
- Publication type:
- Article
21
With a little help from your friends...
- Published in:
- 2003
- Publication type:
- Editorial
22
Innovation through integration.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 8, p. 679, doi. 10.1038/nrd1173
- By:
- Publication type:
- Article